Wanbury Adjusts Evaluation Score Amid Mixed Performance and High Debt Concerns

Wanbury, a microcap player in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in its evaluation score. This revision reflects a shift in technical trends, moving from a bullish stance to a mildly bullish outlook.
The stock's performance indicators reveal a mixed picture. Over the past year, Wanbury has achieved a notable return of 66.16%, significantly outperforming the BSE 500 index. However, its net sales growth has been modest, averaging an annual rate of 10.22% over the last five years. The company's financial health is characterized by a high debt-to-equity ratio of 3.36 times, raising concerns about its long-term fundamental strength. Additionally, a substantial 76.74% of promoter shares are pledged, which could exert downward pressure on the stock in adverse market conditions.

Despite these challenges, Wanbury reported positive results for Q4 FY24-25, marking a turnaround after three consecutive quarters of negative performance. The operating profit to interest ratio has reached a high of 3.28 times, and cash and cash equivalents stand at Rs 12.83 crore, indicating some liquidity strength.

For those interested in tracking the latest developments, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.